Abstracts

1014 – Single-Dose Ceftriaxone Versus Benzathine Penicillin G in Early Syphilis: A Pilot Randomized Trial

Background Ceftriaxone (CRO) shows promising anti-treponemal activity. However, its efficacy for people with early syphilis who often have coexisting bacterial sexually transmitted infections (STIs) remains unclear. This study aimed to compare the efficacy with 1-g, single-dose CRO plus 7-day doxycycline (Doxy) (CRO/Doxy) vs 2.4-MU, single-dose benzathine penicillin G (BPG) plus 7-day Doxy (BPG/Doxy) for the…

282 – Enhancing ADCC Responses in HIV-1 Vaccines: CD4 Incorporation Into Virus-Like Particles (VLPs)

Background The RV144 vaccine trial correlated antibody-dependent cellular cytotoxicity (ADCC) with a reduced risk of HIV infection, highlighting the association between Fc-mediated responses and protective immunity. A promising approach to optimizing ADCC induction is to enhance the exposure of CD4-inducible (CD4i) epitopes, which are responsible for eliciting ADCC responses, on the HIV-1 envelope. These epitopes…

318 – Impact of Hybrid Immunity on Viral Loads, Antigen & Antibodies in Breakthrough SARS-CoV-2 Infection

Background Hybrid immunity, resulting from a combination of both natural SARS-CoV-2 infection and vaccination is common and thought to provide strong protection against infection and severe COVID-19. We evaluated nasopharyngeal (NP) SARS-CoV-2 viral loads, nucleocapsid (N) antigen levels, and the breadth of neutralizing antibodies (nAbs) in adults with hybrid immunity and those without prior infection but vaccinated…

1054 – Population-Representative Consequences of Foreign Aid Instability for HIV Services in South Africa

Background In January 2025, U.S. foreign aid, including the President’s Emergency Plan for AIDS Relief (PEPFAR), was disrupted. While modeling studies have projected population-health consequences, no population-representative studies have quantified disruptions in HIV service-delivery functions. These activities (e.g., patient tracing) and stable procurement of commodities have driven success in the HIV response to date; understanding…

862 – Clinic Transfers and Viral Load Outcomes Among Adolescents and Young Adults With HIV: Western Kenya

Background Retention in HIV care is vital for achieving optimal care for adolescents and young adults living with HIV (AYAH) in sub-Saharan Africa, yet clinic transfers remain common. Limited evidence exists on the characteristics of AYAH who transfer clinics and how transfers influence treatment outcomes. To address this gap, we explored demographic, psychosocial, and clinical factors associated with clinic transfers to identify strategies for…

176 – Pharmacokinetics and Evaluation of Potential Dosing Regimens for Long-Acting VH4524184

Background VH4524184 (VH-184) is a third-generation integrase strand transfer inhibitor (INSTI) with an enhanced in vitro resistance profile compared with second-generation INSTIs. Previously, oral VH-184 demonstrated potent antiviral activity in people with HIV-1 in a proof-of-concept study. Here, we present results from the first-time-in-human study of injectable formulations in adults without HIV to assess the…

194 – Comparative Effectiveness of 3 Benzathine Penicillin G-Based Regimens in PWH With Early Syphilis

Background Compared to single-dose benzathine penicillin G (BPG), BPG plus a 7-day course of doxycycline (Doxy) was recently shown to enhance serologic response (seroresponse) for early syphilis in people with HIV (PWH). Ceftriaxone (CRO) is often added for concurrent gonorrhea, but the additional benefit of ceftriaxone to seroresponse of early syphilis remains uncertain. We aimed…

195 – Early Syphilis and HIV Among Adolescents: United States, 2014-2023

Background Syphilis is an opportunistic infection that can cause substantial morbidity among people with HIV. While sexually transmitted infections (STIs) are common among adolescents, limited data describe national prevalence of syphilis and HIV among this population. We described early syphilis (ES) cases among adolescents with HIV to inform clinical and prevention intervention opportunities. Methods We…